PHARMA PROJECT
Board
2 directors, 1 in day-to-day management, last change in 2024Sole director
since 14-11-2020
term without a fixed end
listed in the 2025 annual accounts, filed on 05-01-2026
Director and managing director
director since 14-11-2020
managing director in office according to the deed of 04-02-2021
6-year term from 2020
listed in the 2025 annual accounts, filed on 05-01-2026
Mandates through the years
4 names, the dashed line is todaySole director
Director, Managing director
Director
Director
LeadershipBoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
-
- Sole director, from 14-11-2020 to date
-
- Director, since before 14-11-2020
- Managing director, since before 14-11-2020
-
- Director, from before 14-11-2020 to 25-01-2024
-
- Director, from before 14-11-2020 to 25-01-2024
Control
Capital
- Capital
- €62,000
- Shares
- 250
- Contribution per share
- €248
- Equity per share
- -€133 in 2025
- Source
- deed of 25-01-2024
Articles of association
deed of 25-01-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Saturday of November at 18:00